Chordin-Like 2: A Possible Therapeutic Target for Gastric Cancer by Affecting Cell Cycle and Proliferation

Figure 1

Gastric cancer had increased CHRDL2 expression. (a) The gene Venn diagrams of the three datasets. (b) Pan-cancer CHRDL2 expression. (c) TCGA database included 210 para-cancerous tissues and 414 unpaired stomach cancer tissues, and CHRDL2 was substantially expressed in tumor tissues.

(a)

(b)

(c)